Literature DB >> 23020307

Exploiting microRNA regulation for genetic engineering.

B Gentner1, L Naldini.   

Abstract

RNA interference (RNAi) has been a landmark discovery in science. A typical application is to knock down the expression of endogenous genes by delivering small interfering RNA (siRNA) into cells triggering the degradation of complementary mRNA. However, RNAi can also be exploited the other way round: making use of the huge diversity of endogenous microRNAs (miRNA), the expression of exogenously introduced genes tagged with artificial miRNA target sequences can be negatively regulated according to the activity of a given miRNA which can be tissue-, lineage-, activation- or differentiation stage specific. This has significantly expanded the regulatory potential of gene transfer vectors and will benefit both basic science and therapeutic applications. This review briefly introduces the reader to the technical basis for exploiting miRNA regulation, followed by a discussion of specific applications for miRNA-regulated vectors/viruses in basic research, gene- and virotherapy.
© 2012 John Wiley & Sons A/S.

Mesh:

Substances:

Year:  2012        PMID: 23020307     DOI: 10.1111/tan.12002

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  15 in total

1.  Gene transfer engineering for astrocyte-specific silencing in the CNS.

Authors:  N Merienne; A Delzor; A Viret; N Dufour; M Rey; P Hantraye; N Déglon
Journal:  Gene Ther       Date:  2015-06-05       Impact factor: 5.250

Review 2.  Improving miRNA Delivery by Optimizing miRNA Expression Cassettes in Diverse Virus Vectors.

Authors:  Elena Herrera-Carrillo; Ying Poi Liu; Ben Berkhout
Journal:  Hum Gene Ther Methods       Date:  2017-08       Impact factor: 2.396

3.  A double-switch vector system positively regulates transgene expression by endogenous microRNA expression (miR-ON vector).

Authors:  Mario Amendola; Alice Giustacchini; Bernhard Gentner; Luigi Naldini
Journal:  Mol Ther       Date:  2013-02-26       Impact factor: 11.454

Review 4.  Strategies for targeting primate neural circuits with viral vectors.

Authors:  Yasmine El-Shamayleh; Amy M Ni; Gregory D Horwitz
Journal:  J Neurophysiol       Date:  2016-04-06       Impact factor: 2.714

Review 5.  MicroRNA-regulated viral vectors for gene therapy.

Authors:  Anja Geisler; Henry Fechner
Journal:  World J Exp Med       Date:  2016-05-20

Review 6.  The retroviral vector family: something for everyone.

Authors:  Carina Elsner; Jens Bohne
Journal:  Virus Genes       Date:  2017-07-31       Impact factor: 2.332

Review 7.  Retroviral vector interactions with hematopoietic cells.

Authors:  Elizabeth M Everson; Grant D Trobridge
Journal:  Curr Opin Virol       Date:  2016-08-10       Impact factor: 7.090

8.  Lentiviral Vector Gene Therapy Protects XCGD Mice From Acute Staphylococcus aureus Pneumonia and Inflammatory Response.

Authors:  Giada Farinelli; Raisa Jofra Hernandez; Alice Rossi; Serena Ranucci; Francesca Sanvito; Maddalena Migliavacca; Chiara Brombin; Aleksandar Pramov; Clelia Di Serio; Chiara Bovolenta; Bernhard Gentner; Alessandra Bragonzi; Alessandro Aiuti
Journal:  Mol Ther       Date:  2016-07-26       Impact factor: 11.454

9.  Identifying HIPK1 as Target of miR-22-3p Enhancing Recombinant Protein Production From HEK 293 Cell by Using Microarray and HTP siRNA Screen.

Authors:  Sarah Inwood; Eugen Buehler; Michael Betenbaugh; Madhu Lal; Joseph Shiloach
Journal:  Biotechnol J       Date:  2017-11-14       Impact factor: 4.677

10.  Construction and identification of the pshRNA-CACNA1G-SH-SY5Ycells targeted to silence Cav3.1 mRNA expression.

Authors:  Xianjie Wen; Shiyuan Xu; Hongzhen Liu; Hua Liang; Chenxiang Yang; Hanbing Wang
Journal:  Biomed Rep       Date:  2013-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.